Global Market Access Strategy Lead, Mezagitamab

Role: Lead global market access and pricing strategy for Mezagitamab (TAK-079), an autoimmune biologic, to ensure optimal reimbursement, patient access, and value realization. Responsibilities: develop and execute global access, pricing, and reimbursement strategies; integrate payer and HTA requirements into clinical development; collaborate with cross-functional teams including R&D, Medical, and International Business Unit; lead development of global access plans, value tools, and training; support launch readiness with local market adaptation; and leverage analytics and digital tools for insights. Requirements: advanced degree (MBA, MPH, PharmD, PhD or equivalent); 8–12 years in pharma/biotech with expertise in global/regional market access, pricing, reimbursement, and payer evidence strategies; strong knowledge of HTA frameworks and reimbursement pathways in major markets (US, EU, Japan, China); experience supporting global product launches and developing access training materials; proven leadership and stakeholder management skills. HighValue: biologics (autoimmune), early development through launch, global markets, payer and HTA engagement, evidence generation, cross-functional leadership, digital and data-driven decision support. WorkSetup: based in Boston, MA, full-time, hybrid; travel not specified but implied for global collaboration.